InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Biobillionair post# 33764

Sunday, 09/07/2014 5:29:02 AM

Sunday, September 07, 2014 5:29:02 AM

Post# of 429566
Assumptions (Based on Q2 2014):

Net revenue / script: $126
GM%: 60,14%
KOWA fee: 9% of Gross Margin
BioPharma: 10% of Net Revenue
Total Operating Expenses: as Q2
Notes interest: 3,5%
One-time expenses (ie.: $8.5 million license fee of ANCHOR to Laxdale) excluded

Break even script number: 43,933 / week
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News